5 Giralda Farms
Madison, NJ 07940
 Synopsis: Business Condition
Year Founded 1926
Employment 47,426
Sector N/A
Industry N/A
Wyeth Inc
     Last modified on: 8/28/2013

Wyeth is now part of Pfizer. Wyeth, Inc. operates as a research-based pharmaceutical and healthcare company in the United States, the United Kingdom, and internationally. Its Pharmaceuticals segment develops, manufactures, distributes, and sells various products, including neuroscience therapies, vaccines, musculoskeletal therapies, nutritional products, gastroenterology drugs, anti-infectives, oncology therapies, hemophilia treatments, immunological products, and women’s healthcare products. This segment offers its products to wholesalers, pharmacies, hospitals, governments, physicians, retailers, and other human healthcare institutions. The company’s Consumer Healthcare segment develops, manufactures, distributes, and sells over-the-counter healthcare products comprising analgesics and heat wraps, cough/cold/allergy remedies, nutritional supplements, and hemorrhoidal care and personal care products. This segment sells these products to wholesalers and retailers. Its Animal Health segment develops, manufactures, distributes, and sells various biological and pharmaceutical products for animals, which include vaccines, pharmaceuticals, internal and external parasite control products, and growth implants. This segment markets its products to wholesalers, veterinarians, and other animal healthcare providers. Wyeth’s product pipeline also includes two Phase III clinical programs in oncology that consist of neratinib (HKI-272), which is under development for the treatment of women with advanced HER-2-positive breast cancer; and bosutinib (SKI-606), a targeted kinase inhibitor under development for the treatment of chronic myelogenous leukemia. The company was formerly known as American Home Products Corporation and changed its name in March 2002. Wyeth, Inc. was incorporated in 1926 and is headquartered in Madison, New Jersey. As of October 15, 2009, Wyeth operates as a subsidiary of Pfizer Inc.